Fig. 1From: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureOverall Survival in Patients with and without Allograft Rejection. aIn one patient identified from the literature, the overall survival after initiation of the checkpoint inhibitor therapy was not availableBack to article page